Kayle Shapero

Kayle Shapero

Auto-generated profile, based on publicly available information

Kayle Shapero

Brown University Health Cardiovascular Institute, Providence, RI (K.S.).

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2025 in Circulation
Verified
Journal Article
Closed access
MCMalamo Countouris
Malamo Countouris
ZMZainab Mahmoud
Zainab Mahmoud
JCJordana B. Cohen
Jordana B. Cohen
DCDaniela Crousillat
Daniela Crousillat
AHAfshan B. Hameed
Afshan B. Hameed
NBNatalie A. Bello
Natalie A. Bello
Hypertension in pregnancy contributes substantially to maternal morbidity and mortality, persistent hypertension, and rehospitalization. Hypertensive disorders of pregnancy are also associated with a heightened risk of cardiovascular disease, and timely recognition and modification of associated risk factors is crucial in optimizing long-term maternal health. During pregnancy, there are expected physiologic alterations in blood pressure (BP); however, pathophysiologic alterations may also occur, leading to preeclampsia and gestational hypertension. The diagnosis and effective management of hypertension during pregnancy is essential to mitigate maternal risks, such as acute kidney injury, stroke, and heart failure, while balancing potential fetal risks, such as growth restriction and preterm birth due to altered uteroplacental perfusion. In the postpartum period, innovative and multidisciplinary care solutions that include postpartum maternal health clinics can help optimize short- and long-term care through enhanced BP management, screening of cardiovascular risk factors, and discussion of lifestyle modifications for cardiovascular disease prevention. As an adjunct to or distinct from postpartum clinics, home BP monitoring programs have been shown to improve BP ascertainment across diverse populations and to lower BP in the months after delivery. Because of concerns about pregnant patients being a vulnerable population for research, there is little evidence from trials examining the diagnosis and treatment of hypertension in pregnant and postpartum individuals. As a result, national and international guidelines differ in their recommendations, and more studies are needed to bolster future guidelines and establish best practices to achieve optimal cardiovascular health during and after pregnancy. Future research should focus on refining treatment thresholds and optimal BP range peripartum and postpartum and evaluating interventions to improve postpartum and long-term maternal cardiovascular outcomes that would advance evidence-based care and improve outcomes worldwide for people with hypertensive disorders of pregnancy.

22 June 2021 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
YKYeunjung Kim
Yeunjung Kim
KSKayle Shapero
Kayle Shapero
SAShawn S. Ahn
Shawn S. Ahn
AGAndrew Michael Goldsweig
Andrew Michael Goldsweig
NDNihar Desai
Nihar Desai
SAS. Elissa Altin
S. Elissa Altin

20 August 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
MCMalamo E. Countouris
Malamo E. Countouris
KSKayle S. Shapero
Kayle S. Shapero
GSGretchen Swabe
Gretchen Swabe
AHAlisse Hauspurg
Alisse Hauspurg
EDEsa M. Davis
Esa M. Davis
JMJared W Magnani
Jared W Magnani
Background: Preeclampsia is associated with increased cardiovascular morbidity and death. Primary care or cardiology follow‐up, in complement to routine postpartum obstetric care, provides an essential opportunity to address cardiovascular risk. Prior studies investigating racial differences in the recommended postpartum follow‐up have incompletely assessed the influence of social factors. We hypothesized that racial and ethnic differences in follow‐up with a primary care provider or cardiologist would be modified by income and education. Methods and Results: We identified adult individuals with preeclampsia (September 2014 to September 2019) in a national administrative database. We compared occurrence of a postpartum visit with a primary care provider or cardiologist within 1 year after delivery by race and ethnicity using multivariable logistic regression models. We examined whether education or income modified the association between race and ethnicity and the likelihood of follow‐up. Of 18 050 individuals with preeclampsia (aged 31.8±5.7 years), Black individuals (11.7%) had lower odds of primary care provider or cardiology follow‐up within 1 year after delivery compared with White individuals (adjusted odds ratio, 0.77 [95% CI, 0.70–0.85]) as did Hispanic individuals (14.8%; adjusted odds ratio, 0.79 [95% CI, 0.73–0.87]). Black and Hispanic individuals with higher educational attainment were more likely to have follow‐up than those with lower educational attainment ( P for interaction=0.033) as did those in higher income brackets ( P for interaction=0.006). Conclusions: We identified racial and ethnic differences in primary care or cardiology follow‐up in the year postpartum among individuals diagnosed with preeclampsia, a disparity that may be modified by social factors. Enhanced system‐level interventions are needed to reduce barriers to follow‐up care.

19 June 2019 in Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
PDF file
KSKayle S. Shapero
Kayle S. Shapero
QJQurat-Ul-Ain Jelani
Qurat-Ul-Ain Jelani
CMCarlos Mena
Carlos Mena
Inferior vena cava (IVC) thrombosis is a specific form of thromboembolism that occurs at a rate of 1.5% in all patients hospitalized with a deep vein thrombosis. Malignant IVC thrombosis may occur due to compression from a tumor mass or metastasis or may also occur through tumor invasion of the venous vasculature. Obstruction of the IVC can lead to IVC syndrome, marked by ascites, lower extremity edema, and even congestive hepatic failure. We present a case of extensive IVC thrombosis in a 69-year-old female with metastatic adrenal cell carcinoma, presenting with severe bilateral lower extremity edema and ascites. Computed tomography showed IVC compression by the caudate lobe due to a metastatic liver mass and extensive clot burden of the IVC extending from the renal veins to the right atrium (RA). She underwent percutaneous IVC stenting with 4 stents placed in tandem from the IVC to the RA. Her hospital course was complicated by gastrointestinal bleed requiring clipping, acute liver failure, and hypophysitis due to trial therapy. Although her IVC symptoms were partially relieved with percutaneous intervention, her acute liver failure worsened and she was ultimately transitioned to hospice care.

1 April 2021 in Acta Histochemica
Verified
Journal Article
Closed access
AXAlexander A. Xu
Alexander A. Xu
KSKayle S. Shapero
Kayle S. Shapero
JGJared A. Geibig
Jared A. Geibig
HMHsiang-Wei K. Ma
Hsiang-Wei K. Ma
AJAlex R. Jones
Alex R. Jones
RPRobert A. Peattie
Robert A. Peattie

1 September 2023 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
KSKayle Shapero
Kayle Shapero
SESami El-Dalati
Sami El-Dalati
KBKathryn Berlacher
Kathryn Berlacher
CMChristina Megli
Christina Megli
The incidence of infective endocarditis (IE) in pregnancy is rare (0.006%), with increasing prevalence during the opioid epidemic. IE in pregnancy is associated with high rates of mortality and morbidity, and existing data on outcomes in pregnancy are limited. Our study compares the outcomes of pregnant patients with IE with those of nonpregnant patients. Patients diagnosed with IE during pregnancy and 30 days postpartum between 2014 and 2021 were identified by International Classification of Diseases, Clinical Modification, Ninth and Tenth Edition codes. Pregnant cases were matched to nonpregnant reproductive-age endocarditis patients in a 1:4 ratio. Data were collected and validated through chart review. One hundred eighty patients with IE were identified; 34 were pregnant or within 30 days postpartum at diagnosis. There were higher rates of hepatitis C and opioid maintenance therapy in the pregnant patients. The etiology of IE in pregnant patients was predominantly S. aureus (methicillin-resistant/sensitive S. aureus), whereas nonpregnant woman had greater microbiological variation. We observed comparable rates of valve replacement (32.4% vs 29%; P = .84) and 2-year mortality (20.6% vs 17.8%; P > .99) in pregnant patients. There were nonsignificantly higher rates of pulmonary emboli (17.6% vs 7.5%; P = .098) and arrhythmia (17.6% vs 9.6%; P = .222) among pregnant patients. There were high rates of intravenous drug use relapse in both groups (>40%). We observed similar rates of mortality in the pregnant IE patients. We observed a microbial predilection for S. aureus in pregnancy, suggesting that the pregnancy physiology may select for this microbiologic etiology. This study, which represents the largest single-center retrospective review of IE in pregnancy, suggests that surgical intervention may be performed safely in the postpartum period.